Scientifically speaking - Present with impact
VCCC Alliance Leadership Academy Series
Presented by Ms Ingrid Svendsen OAM GAICD
Monday Lunch Live
24 July 2023
Ultra-rapid genomic testing has the potential to significantly alter clinical outcomes in rare disease by providing timely information to guide therapy and treatment decisions.
In this webinar, Profesor Zornitza Stark and…
Monday Lunch Live
3 April 2023
Health treatment changes rapidly, but health policy is slower to evolve. Why haven't health system challenges been addressed by now?
In this presentation, Professor Stephen Duckett describes some of the key contemporary…
Monday Lunch Live
7 August 2023
…Providing Registry-based Clinical Trial (Reg-CT) related training to our workforce to increase the number of Reg-CTs available nationally.
Aim:
This course aims to increase our clinical trial workforce and enable clinical trial professionals to…
VCCC Alliance Breast Cancer Grand Round with Associate Professor Kylie Gorringe
Molecular Analyses of Pre-Invasive Breast Disease
Join us for a deep dive into the genomic secrets of pre-invasive breast diseases with Associate Professor Kylie Gorringe, a renowned scientist at…
VCCC Alliance Breast Cancer Grand Round with Dr Cameron Snell
The use of digital algorithms in the management of breast cancer
14 June 2023
Breast cancer classification relies on immunohistochemical assays for ER, PR, HER2, and ki-67, which are…
VCCC Alliance Breast Cancer Grand Round with Dr Alexandra Murphy
Optimising Cardiovascular Outcomes in Oncology Patients
We are proud to present a masterclass in cardio-oncology with cardiologist, Dr Alexandra Murphy. With a wealth of knowledge gained from her…
Breast Cancer Education Series hosted by Dr Cameron Snell
Difficulties in pathological classification of breast lesions on core biopsies
Explore challenges in diagnosing breast lesions, gain insights from real case studies, and engage in thought-provoking discussions with Dr…
Monday Lunch Live
14 August 2023
Take a deep dive into the opportunities and limitations of new trial methodologies and their implementation - specifically, registry trials and teletrials.
Both of these trial types show a lot of promise, with early data…